PRIOR TO RITUXAN HYCELA USE 1

All patients must first receive at least one full dose of RITUXAN (rituximab) without experiencing severe adverse reactions before starting treatment with RITUXAN HYCELA due to the higher risk of hypersensitivity and other acute reactions during the first infusion

  • Beginning therapy with RITUXAN allows management of hypersensitivity and other administration reactions by slowing or stopping the intravenous infusion
  • If patients are not able to receive one full dose of RITUXAN, they should continue subsequent cycles with RITUXAN and not switch to RITUXAN HYCELA until a full RITUXAN dose is successfully administered

PRODUCT INFORMATION AND STORAGE 1

Packaged in single-dose vials and delivered in a fixed dose, RITUXAN HYCELA does not require dilution and BSA calculations

  • Individually packaged single-dose vials
  • Fixed dose
  • Ready-to-use vials
  • RITUXAN HYCELA should be a clear to opalescent and colorless to yellowish liquid. Do not use vial if particulates or discoloration is present
  • RITUXAN HYCELA vials must be refrigerated at 36ºF–46ºF (2ºC–8ºC)
  • Do not freeze
  • Store RITUXAN HYCELA vials in the original carton to protect from light
Watch the Dosing & Administration Video
Download the RITUXAN HYCELA Dosing & Administration Brochure